Board Meeting Announcement for Oxygenta Pharmaceutical Ltd - May 30, 2025

Audited Results - Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the company will be held on Friday, May 30, 2025, inter alia, to consider the audited financial results of the Company for the Fourth quarter and Financial Year ended on March 31, 2025 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015. In continuation to our earlier intimation of closure of trading window, we would like to inform that the trading window of the Company for all the designated persons and their immediate relatives will remain closed till June 01, 2025, which is 48 hours after the said Board Meeting.